IP Library Granted Patent US 10,968,256
Granted Patent B2
US 10,968,256 · App. 15/761,598 · Granted Apr 6, 2021

Optogenetic system based on bacterial phytochrome controllable with near infra-red light

Inventors: Vladislav V. Verkhusha (Bronx, NY); Andrii A. Kaberniuk (Bronx, NY); Anton A. Shemetov (New York, NY)
Assignee: Albert Einstein College of Medicine
C07K14/195A61H31/005A61H31/007A61K41/0042A61N1/3937A61N1/3993A61H2201/10A61H2201/5007A61H2201/5043A61H2201/5084A61H2201/5097A61H2230/06C07K2319/00C07K2319/60C07K2319/80
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,968,256
App. No.
15/761,598
Granted
Apr 6, 2021
Kind
B2
Abstract

A novel optogenetic system, including constructs and methods, is provided based on the interaction of Rhodopseudomonas palustris BphP1 and Rhodopseudomonas palustris PpsR2 or a non-dimerizing variant thereof.

Claims (21)

1. A method for inducing interaction of a first protein with a second protein in a system, the method comprising providing a system comprising

(a) a first fusion protein comprising (i) a protein having the sequence of a Rhodopseudomonas palustris bacterial phytochrome RpBphP1 (BphP1) and (ii) the first protein, and

(b) a second fusion protein comprising (i) a protein having the sequence of a Rhodopseudomonas palustris transcriptional repressor RpPpsR2 (PpsR2) or a non-dimerizing variant thereof, wherein the non-dimerizing variant of PpsR2 has an amino acid sequence of SEQ ID NO:3 and (ii) the second protein, and

(c) an amount of biliverdin; and irradiating the system with near infrared light sufficient to induce interaction of a Rhodopseudomonas palustris BphP1 with a Rhodopseudomonas palustris PpsR2 or a non-dimerizing variant thereof, wherein the non-dimerizing variant of PpsR2 has an amino acid sequence of SEQ ID NO:3.

2. The method of claim 1 , wherein the first or second protein is a DNA-binding protein.

3. The method of claim 1 , wherein the first or second protein comprises a transcriptional activator protein.

4. The method of claim 1 , wherein at least one of the first fusion protein and the second fusion protein further comprises a detectable marker protein or detectable marker peptide.

5. The method of claim 4 , wherein the first fusion protein and the second fusion protein comprise different detectable marker proteins which are each fluorescent proteins.

6. The method of claim 1 , wherein the system is a eukaryotic cell.

7. The method of claim 6 , further comprising providing the system by transfecting the cell with a nucleic acid encoding the first fusion protein comprising a protein having the sequence of a Rhodopseudomonas palustris bacterial phytochrome RpBphP1 (BphP1).

8. The method of claim 6 , further comprising providing the system by transfecting the cell with a nucleic acid encoding the second fusion protein comprising a protein having the sequence of a Rhodopseudomonas palustris transcriptional repressor RpPpsR2 (PpsR2) or a non-dimerizing variant thereof and the second protein.

9. A method for inducing translocation of a predetermined protein to a predetermined location in a cell comprising providing a system comprising

(a) a first fusion protein comprising (i) a protein having the sequence of a Rhodopseudomonas palustris bacterial phytochrome RpBphP1 (BphP1) and (ii) a first protein,

(b) a second fusion protein comprising (i) a protein having the sequence of a Rhodopseudomonas palustris transcriptional repressor RpPpsR2 (PpsR2) or a non-dimerizing variant thereof, wherein the non-dimerizing variant of PpsR2 has an amino acid sequence of SEQ ID NO:3 and (ii) a second protein, and

(c) an amount of biliverdin, wherein one of the first and second proteins is the predetermined protein and wherein the other of the first and second proteins is a protein that preferentially locates to the predetermined location in a cell; and irradiating the system with near infrared light sufficient to induce interaction of a Rhodopseudomonas palustris BphP1 with a Rhodopseudomonas palustris PpsR2 or a non-dimerizing variant thereof, wherein the non-dimerizing variant of PpsR2 has an amino acid sequence of SEQ ID NO:3.

10. The method of claim 9 , wherein the protein that preferentially locates to the predetermined location in a cell, preferentially locates to a plasma membrane of a cell.

11. The method of claim 9 , wherein the protein that preferentially locates to the predetermined location in a cell, preferentially locates to an organelle of a cell.

12. The method of claim 9 , wherein the protein that preferentially locates to the predetermined location in a cell, preferentially locates to a nucleus of a cell.

13. The method of claim 12 , wherein the first fusion protein comprising the first protein or the second fusion protein comprising the second protein that preferentially locates to a nucleus, further comprises a DNA-binding protein.

14. The method of claim 12 , wherein the first fusion protein comprising the first protein or the second fusion protein comprising the second protein that preferentially locates to a nucleus, further comprises a transcriptional activator protein.

15. The method of claim 9 , wherein at least one of the first fusion protein and the second fusion protein further comprises a detectable marker protein or detectable marker peptide.

Assignments (1)
MERGER AND CHANGE OF NAME Recorded Feb 26, 2019
From: ALBERT EINSTEIN COLLEGE OF MEDICINE, INC.; ALBERT EINSTEIN COLLEGE OF MEDICINE
To: ALBERT EINSTEIN COLLEGE OF MEDICINE
Reel/Frame 048438/0275 →
Continuity (2)
Provisional Application 62235828 · Oct 1, 2015
Related Publication 20180346523A1 · Dec 6, 2018